An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

NCT06010472 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

DRUG: anti-CD19 CAR NK cells (KN5501)

Sponsor

Changhai Hospital

Collaborators

[object Object]